Facebook
X
LinkedIn
Forward
RWE in Action: Using the AMCP RWE Standards to Facilitate Formulary Decisions
Pricing: Free for Members and Non-Members
Course Description
Real-world evidence (RWE), generated from real-world data (RWD), has great potential to expand the totality of evidence and bridge the gap between research and its implementation in clinical care. The AMCP Research Institute has created the AMCP RWE Standards as part of our RWE Initiative to facilitate efficient communication and use of RWE in payer decision-making processes. Attendees will be presented with hypothetical data from clinical trials and RWE studies, communicated in accordance with the RWE Standards best practices, to demonstrate how different evidence can influence or change decisions and impact confidence in the initial decisions made. Through an interactive discussion, panelists will take attendees through the formulary decision-making process following the AMCP RWE Standards, using the hypothetical data as the use case. Participants will learn practical approaches to obtaining RWE, assessing study quality, and interpreting findings, and will gain a comprehensive understanding of how to use the AMCP RWE Standards to inform strategic decision-making.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Describe why real-world evidence (RWE) is important for payer decision-making.
- Discuss the AMCP RWE Standards and how the standards can help payers incorporate RWE into their formulary decision processes.
- Review a RWE study to explore how to assess quality and rigor for payer or formulary decision-making.
Pat Gleason, PharmD
Assistant Vice President
Prime Therapeutics
Cate Lockhart, PharmD, PhD
Chief Science Officer
AMCP
Elizabeth Powers, MBA
VP, Real World Data Acquisition
IQVIA Inc.
Brian Sweet, BS Pharm, MBA
Executive Director, Health Economics & Outcomes Research
Geron
Disclosures
| Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
| Pat Gleason Faculty | Employee: Prime Therapeutics |
| Cate Lockhart Faculty | Research Funding: Eli Lily and Company |
| Brian Sweet Faculty | Employee: Geron |
| Erika Kaplan Peer Reviewer | PerformRx (Clinical Pharmacist) |
| Brooke Whittington Planner | Disclosed no relevant financial relationships |
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN: 0233-0000-26-007-L04-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: April 20, 2026 • Expiration Date: December 31, 2027
Activity Fee: Free for Members and Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP 2026. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.25 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.